This session will explore the evolving landscape of cancer screening in veterinary medicine through the lens of human oncology. By examining the historical progression of cancer screening in people -- from reactive diagnosis to proactive, population-level screening -- we will highlight how similar trends are emerging in veterinary practice. In human medicine, screening tools such as mammography, colonoscopy and liquid biopsy have improved early detection, outcomes, and survivability. Veterinary oncology appears to be following a similar path, with innovations like liquid biopsy enabling earlier, less invasive cancer detection in pets. These technologies are shifting the focus from diagnosing cancer at the point of clinical illness to identifying disease at potentially an earlier stage. Attendees will gain insight into how veterinary cancer screening is rapidly evolving, what we can learn from decades of progress in human medicine, and how proactive diagnostics can redefine the continuum of care in companion animals. This presentation will also address current patterns of implementation, limitations, and future directions for integrating screening strategies into everyday veterinary practice.

DATE: